Sen. Kate Bolz of Lincoln introduced legislation Monday to improve insulin affordability in Nebraska.
The bill caps the total co-pay for a one month supply of insulin at $100. Over the past fourteen years, the out of pocket cost of many insulin brands increased 555% adjusted for inflation, according to the American Medical Association.
“For the 174,000 Nebraskans with diabetes, the spike in insulin costs is a real problem,” Bolz said. “These are our relatives, friends and neighbors who have to make decisions they know will damage their health, simply because they can no longer afford their insulin dosage.”
According to the American Medical Association, nearly 1 in 4 diabetics have reported rationing or skipping insulin doses because of cost. Deviating from prescribed insulin can result in serious complications, including heart disease, stroke, amputation, end-stage kidney disease, blindness, and death.
From 2012-16, the average annual cost of insulin nationwide has increased from $2,900 per year to $5,700. Currently, no medication is known to substitute for insulin to manage diabetes. Bolz said.
Kate Bolz represents District #29 in the Nebraska Legislature.